Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus- 6, 11, 16, 18”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Large-scale testing (Phase 3)Study completedNCT00092521
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 5,759
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Testing effectiveness (Phase 2)Study completedNCT00710593
What this trial is testing

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 99
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT01030562
What this trial is testing

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

Who this might be right for
Papilloma Viral Infection
National Institute of Allergy and Infectious Diseases (NIAID) 1,321
Testing effectiveness (Phase 2)Study completedNCT01687192
What this trial is testing

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

Who this might be right for
TransplantationSystemic Lupus ErythematosusSystemic Immune Disease
University Hospital, Bordeaux 37
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Testing effectiveness (Phase 2)Study completedNCT00365716
What this trial is testing

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Who this might be right for
Papillomavirus InfectionsGenital Diseases, Female
Merck Sharp & Dohme LLC 1,158
Post-approval studies (Phase 4)Study completedNCT01544478
What this trial is testing

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Who this might be right for
Cervical CancerCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ
Merck Sharp & Dohme LLC 1,030